<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02500290</url>
  </required_header>
  <id_info>
    <org_study_id>FPS-AAS-2014-01</org_study_id>
    <nct_id>NCT02500290</nct_id>
  </id_info>
  <brief_title>Antiplatelet Therapy in Acute Coronary Syndrome(ACS). Safety and Efficacy of Switching Antiplatelet</brief_title>
  <official_title>Antiplatelet Therapy in Acute Coronary Syndrome (ACS). Safety and Efficacy of Switching Antiplatelet</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación Pública Andaluza Progreso y Salud</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to describe antiplatelet therapy in ACS in Andalusia and make an assessment
      of efficacy and safety of hospital use Prasugrel / ticagrelor vs. Clopidogrel and Prasugrel
      switching to / ticagrelor patients pretreated with clopidogrel.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The management of acute coronary syndrome has changed in recent years as reflected in the new
      Clinical Practice Guidelines of the European Society of Cardiology for the management of ACS
      with or without ST segment elevation, with the development and increased accessibility of the
      angiography and percutaneous coronary intervention and the arrival of the new antiplatelet
      (Prasugrel and Ticagrelor).

      The ACS encompasses several clinical entities where dual antiplatelet therapy remains the
      basis of antiplatelet therapy and one of the mainstays of treatment. But the emergence of
      Prasugrel and Ticagrelor have changed the classical management with aspirin plus clopidogre
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>type of antiplatelet were used</measure>
    <time_frame>12 months</time_frame>
    <description>There are the following therapeutic groups:
Clopidogrel; Prasugrel; Ticagrelor; Switching to Prasugrel ; Switching toTicagrelor</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ischemic events after ACS during hospitalization</measure>
    <time_frame>3, 6 and 12 months</time_frame>
    <description>Ischemic event is defined as the combined end point of stroke, reinfarction, stent thrombosis, restenosis and stent injury retreat previously treated
1. thrombotic complications: stroke, stent restenosis, retreat of the culprit vessel, stent thrombosis, CVA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total rate of hemorrhage and severity thereof under TIMI9 and BARC15 classification. Also it included as a safety endpoint all-cause mortality.</measure>
    <time_frame>3, 6 and 12 months</time_frame>
    <description>bleeding complications: BARC, TIMI classification, transfusions, major bleedingbleeding complications: BARC, TIMI classification, transfusions, major bleeding</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <arm_group>
    <arm_group_label>Acute coronary syndrome</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed with acute coronary syndrome
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients admitted to the Coronary Care Unit at the time defined with an initial
             diagnosis of ACS.

        Exclusion Criteria:

          -  Myocarditis, Takotsubo syndrome, pulmonary thromboembolism.

          -  Secondary MI or type 2, caused by an increase in demand or decrease oxygen (anemia,
             tachycardia, hypotension, heart failure, etc.). 11

          -  Patients under 18 years.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manuel Almedro Delia, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Universitario Virgen Macarena</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Manuel Almedro Delia, MD</last_name>
    <phone>955 00 80 00</phone>
    <email>trocor@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>María del Mar Benjumea Vargas</last_name>
    <phone>955 04 04 60</phone>
    <email>gestiondeensayosclinicos.fps@juntadeandalucia.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital de Jerez</name>
      <address>
        <city>Cádiz</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Julián Arias Garrido, MD</last_name>
      <email>jjarias55@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Jose Julián Arias Garrido, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Puerto Real</name>
      <address>
        <city>Cádiz</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Carlos Rodríguez Yañez, MD</last_name>
      <email>rodya3@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Juan Carlos Rodríguez Yañez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Reina Sofía</name>
      <address>
        <city>Córdoba</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gemma Alonso Muñoz, MD</last_name>
      <email>gema-aaron@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Gemma Alonso Muñoz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miguel Angel Chirosa Ríos, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tania Amat Serna, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de las Nieves</name>
      <address>
        <city>Granada</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Reina Toral, MD</last_name>
      <email>antoniorein@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Antonio Reina Toral, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Antequera</name>
      <address>
        <city>Málaga</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Varela López, MD</last_name>
      <email>varela.anto@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Antonio Varela López, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Regional de Málaga</name>
      <address>
        <city>Málaga</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>José Andrés Arboleda Sánchez, MD</last_name>
      <email>arboledaja@gmail.com</email>
    </contact>
    <investigator>
      <last_name>José Andrés Arboleda Sánchez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de la Victoria</name>
      <address>
        <city>Málaga</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ángel García Alcántara, MD</last_name>
      <email>med000859@telefonica.net</email>
    </contact>
    <investigator>
      <last_name>Angel García Alcántara, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen Macarena</name>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manuel Almendro Delia, MD</last_name>
      <phone>955 00 80 00</phone>
      <email>trocor@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Juan Carlos García Rubiera, MD</last_name>
      <email>grubira@wanadoo.es</email>
    </contact_backup>
    <investigator>
      <last_name>Manuel Almendro Delia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juan Carlos García Rubira, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emilia Blanco Ponce, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 7, 2015</study_first_submitted>
  <study_first_submitted_qc>July 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 16, 2015</study_first_posted>
  <last_update_submitted>May 2, 2017</last_update_submitted>
  <last_update_submitted_qc>May 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ACS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

